FDA Authorizes New Monoclonal Antibody that Retains Activity Against Omicron Variant
U.S. Food and Drug Administration issued an emergency use authorization (EUA) for a new monoclonal antibody for ...
Read moreU.S. Food and Drug Administration issued an emergency use authorization (EUA) for a new monoclonal antibody for ...
Read moreAiming to increase access to recommended treatments for COVID-19, WHO today added tocilizumab, a monoclonal antibody, ...
Read moreWockhardt Limited on Tuesday said that it has received permission from the Central Drugs Standard Control ...
Read moreSputnik Light is the latest vaccine to be approved in India as part of the national ...
Read moreNuvaxovid™ is the first protein-based COVID-19 vaccine to receive provisional approval for distribution in New Zealand ...
Read moreNearly 87% of naturally infected COVID-19 patients maintained antibodies to SARS-CoV-2 proteins for at least 10 ...
Read moreNatco Pharma Limited announced the signing of a royalty-free, non-exclusive, voluntary licensing agreement with Eli Lilly ...
Read moreAnti Covid drug 2-DG launched by Defence Minister and Health Minister 2-DG developed by DRDO in ...
Read moreHester bioscience limited ties up with Gujarat Biotechnology Research Centre, Department of Science & Technology, Government ...
Read moreThe COVID Working Group chaired by Dr N K Arora has recommended extension of the gap ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.